Reporter’s Commentary: In recent decades, mainstream institutions and media have stopped discussing human deworming. Meanwhile, international financial conglomerates and criminal forces have deliberately developed bacterial parasites to be used as biological weapons. They have found ways to inject them into the human body using vaccines as bait, and even implant them deep into the nasal cavity near the brainstem, under the guise of PCR nasal tests. The so-called conspiracy theories have now been exposed and confirmed. During the early days of the Wuhan virus outbreak, I came across a Chinese patent document in biomedical literature that was unsettling to read. It stated that the research had been completed, and the next step was to figure out how to introduce it into the human body. / France: Freedom, Health, and Human Rights Reporter: Han Rongli
FOCAL POINTS (COURAGEOUS DISCOURSE) NEW STUDY: Fenbendazole Linked to Remission or Near-Remission in Three Stage IV Cancer Patients Breast, prostate, and melanoma patients experienced dramatic tumor regression and long-lasting remission — without chemotherapy. NICOLAS HULSCHER, MPH 18 AUG 2025 AT 22:14
by Nicolas Hulscher, MPH Fenbendazole (FBZ) is a low-cost veterinary antiparasitic drug that has gained global attention as a potential anticancer therapy. Like ivermectin—another antiparasitic widely repurposed in research and clinical practice for its potent anti-tumor effects—fenbendazole appears to work far beyond its original veterinary use.
Preclinical studies show fenbendazole disrupts cancer cell survival through multiple pathways, but until now, human evidence has been scarce. A newly published case series by Dr. William Makis et al in Case Reports in Oncology presents three remarkable patients with advanced, stage IV cancers (breast, prostate, and melanoma) who self-administered Fenbendazole outside conventional oncology protocols. All three achieved either complete or near-complete remission — sustained for up to three years — without chemotherapy:
臨床前研究表明，芬苯達唑透過多種途徑破壞癌細胞的生存，但到目前為止，人類證據很少。
博士新出版的案例系列。 William Makis等人在《腫瘤學病例報告》中介紹了三名患有晚期IV期癌症（乳腺癌、前列腺癌和黑色素瘤）的傑出患者，他們在常規腫瘤學方案之外自行服用芬苯達唑。 這三者都實現了完全或幾乎完全緩解——持續長達三年——無需化療：
驱虫药与癌症 附记者评述
记者评述：近几十年来，主流机构及媒体不再提及人体驱虫，而且，多年来国际财团黑恶势力傀儡蓄意研制细菌寄生虫用作生物武器，并设法以疫苗为诱饵注入人体、以PCR鼻逆子为借口植入鼻腔深部靠近大脑中枢。…所谓阴谋论、都已经被戳穿证实。…中共武汉病毒爆发初期，记者阅读了一篇中国专利资料生物医学文献，该文惊悚写到，东西是研究出来了、接下来就要看看如何放入人体。/ 法国：自由健康人权记者：韩荣利
Anthelmintic Drugs, Deworming Drugs, and Cancer - With Reporter’s Commentary
https://open.substack.com/pub/petermcculloughmd/p/new-study-fenbendazole-linked-to
Reporter’s Commentary: In recent decades, mainstream institutions and media have stopped discussing human deworming. Meanwhile, international financial conglomerates and criminal forces have deliberately developed bacterial parasites to be used as biological weapons. They have found ways to inject them into the human body using vaccines as bait, and even implant them deep into the nasal cavity near the brainstem, under the guise of PCR nasal tests. The so-called conspiracy theories have now been exposed and confirmed. During the early days of the Wuhan virus outbreak, I came across a Chinese patent document in biomedical literature that was unsettling to read. It stated that the research had been completed, and the next step was to figure out how to introduce it into the human body. / France: Freedom, Health, and Human Rights Reporter: Han Rongli
FOCAL POINTS (COURAGEOUS DISCOURSE)
NEW STUDY:
Fenbendazole Linked to Remission or Near-Remission in
Three Stage IV
Cancer Patients
Breast, prostate, and melanoma patients experienced dramatic tumor regression and long-lasting remission — without chemotherapy.
NICOLAS HULSCHER, MPH
18 AUG 2025 AT 22:14
焦點（勇敢的論述）
新研究：
芬苯達唑與緩解或接近緩解有關
第三階段IV
癌症患者
乳房、前列腺和黑色素瘤患者在沒有化療的情況下經歷了戲劇性的腫瘤消退和長期緩解。
尼古拉斯·赫爾舍
作者：Nicolas Hulscher，MPH
芬苯達唑（FBZ）是一種低成本的獸醫抗寄生蟲藥物，作為一種潛在的抗癌療法獲得了全球的關注。 與伊維菌素一樣，芬苯達唑是一種在研究和臨床實踐中因其強大的抗腫瘤作用而被廣泛重新利用的抗寄生蟲劑，芬苯達唑似乎遠遠超出了其最初的獸醫用途。
by Nicolas Hulscher, MPH
Fenbendazole (FBZ) is a low-cost veterinary antiparasitic drug that has gained global attention as a potential anticancer therapy. Like ivermectin—another antiparasitic widely repurposed in research and clinical practice for its potent anti-tumor effects—fenbendazole appears to work far beyond its original veterinary use.
Preclinical studies show fenbendazole disrupts cancer cell survival through multiple pathways, but until now, human evidence has been scarce.
A newly published case series by Dr. William Makis et al in Case Reports in Oncology presents three remarkable patients with advanced, stage IV cancers (breast, prostate, and melanoma) who self-administered Fenbendazole outside conventional oncology protocols. All three achieved either complete or near-complete remission — sustained for up to three years — without chemotherapy:
臨床前研究表明，芬苯達唑透過多種途徑破壞癌細胞的生存，但到目前為止，人類證據很少。
博士新出版的案例系列。 William Makis等人在《腫瘤學病例報告》中介紹了三名患有晚期IV期癌症（乳腺癌、前列腺癌和黑色素瘤）的傑出患者，他們在常規腫瘤學方案之外自行服用芬苯達唑。 這三者都實現了完全或幾乎完全緩解——持續長達三年——無需化療：